Fig. 3From: Profiling of patient-specific myocytes identifies altered gene expression in the ophthalmoplegic subphenotype of myasthenia gravisa and b. Expression of muscle gene transcripts in myocytes by subphenotype in early (48 h) and late (5 days) differentiation models. RNA was extracted from untreated control MG (n = 6) and OP-MG (n = 10) myocytes after 48 h and 5 days of differentiation as described. For each differentiation time point, expression levels of CHRNA1, MYOD1 and MYOG target genes were determined using relative quantification (2-∆Cq) where ∆Cq represents target gene Cq – average GUSB/TFRC Cq (the reference genes which were not influenced by prolonged differentiation of myocytes). a Combined log2 fold change for both subphenotypes (mean 2-∆∆Cq, where ∆∆Cq represents 5 days ∆Cq - 48 h ∆Cq) were compared to assess differences in gene expression levels between the early and late differentiation models. b Comparison of gene expression levels (2-∆Cq) between subphenotypes in the early and late differentiation models. c CHRNA1 P3A+ isoform expression in OP-MG and control MG myocytes represents in vivo muscle splicing signatures. RNA was extracted from control MG (n = 6) and OP-MG (n = 10) myocytes after 5 days of differentiation as described. qPCR was performed using two sets of primers for CHRNA1: 1 set which recognizes total CHRNA1 transcripts (P3A+ and P3A-) and another which is specific for P3A+ transcripts. Cq values were used to interpolate absolute transcript numbers from standard curves, then the ratio of P3A+:(P3A+ and P3A-) was calculated for each sample (expressed as %). Error bars show mean and SEM. Student’s t test was used for comparisons where the data was normally distributed, otherwise Mann-Whitney test was used (†) where Shapiro-Wilk normality test p < 0.05Back to article page